Treatment of Breast Cancer-Bearing BALB/c Mice with Magnetic Hyperthermia using Dendrimer Functionalized Iron-Oxide Nanoparticles.
breast cancer
dendrimer
iron oxide nanoparticles
magnetic hyperthermia
Journal
Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216
Informations de publication
Date de publication:
22 Nov 2020
22 Nov 2020
Historique:
received:
23
10
2020
revised:
14
11
2020
accepted:
20
11
2020
entrez:
3
12
2020
pubmed:
4
12
2020
medline:
4
12
2020
Statut:
epublish
Résumé
The development of novel nanoparticles for diagnostic and therapeutic applications has been one of the most crucial challenges in cancer theranostics for the last decades. Herein, we functionalized iron oxide nanoparticles (IONPs) with the fourth generation (G
Identifiants
pubmed: 33266461
pii: nano10112310
doi: 10.3390/nano10112310
pmc: PMC7700443
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Biomaterials. 2013 Oct;34(32):7873-83
pubmed: 23876757
Acta Biomater. 2012 Jul;8(7):2704-11
pubmed: 22484694
ACS Nano. 2012 Jun 26;6(6):5266-73
pubmed: 22588093
Cancer Nanotechnol. 2018;9(1):7
pubmed: 30363777
Sci Rep. 2016 Jun 03;6:27136
pubmed: 27256519
Cell Death Dis. 2017 Apr 13;8(4):e2749
pubmed: 28406478
Int J Nanomedicine. 2018 Mar 13;13:1483-1493
pubmed: 29559777
Nanomaterials (Basel). 2020 Feb 08;10(2):
pubmed: 32046284
Nano Lett. 2019 Jun 12;19(6):3618-3626
pubmed: 31074627
J Biomed Biotechnol. 2009;2009:457936
pubmed: 19830247
J Urol. 2003 Dec;170(6 Pt 1):2163-72
pubmed: 14634372
PLoS One. 2017 May 4;12(5):e0177049
pubmed: 28472102
Nanomedicine. 2011 Dec;7(6):1001-8
pubmed: 21515406
Nanomaterials (Basel). 2020 Jun 26;10(6):
pubmed: 32604768
Sci Rep. 2016 Apr 22;6:24629
pubmed: 27103308
J Nanobiotechnology. 2016 Jun 22;14(1):50
pubmed: 27334629
Pharmaceuticals (Basel). 2017 Dec 23;11(1):
pubmed: 29295496
Nat Nanotechnol. 2011 Jun 26;6(7):418-22
pubmed: 21706024
Biomaterials. 2017 Jul;132:16-27
pubmed: 28399459
Eur J Pharm Sci. 2009 Oct 8;38(3):185-96
pubmed: 19646528
Breast. 2018 Feb;37:163-169
pubmed: 29246526
J Mater Chem B. 2015 Oct 28;3(40):7831-7849
pubmed: 32262898
Nanoscale Res Lett. 2014 May 21;9(1):247
pubmed: 24994950
Int J Hyperthermia. 2008 Mar;24(2):123-40
pubmed: 18283589
Langmuir. 2005 Nov 8;21(23):10348-54
pubmed: 16262291
Biomicrofluidics. 2010 Jun 21;4(2):
pubmed: 20697578
Sci Rep. 2017 Feb 20;7:42783
pubmed: 28218292
Breast Cancer Res. 2015 May 13;17:66
pubmed: 25968050
Drug Discov Today. 2001 Apr 1;6(8):427-436
pubmed: 11301287
Histopathology. 1991 Nov;19(5):403-10
pubmed: 1757079
Beilstein J Nanotechnol. 2016 Oct 28;7:1532-1542
pubmed: 28144504
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Biomacromolecules. 2017 Apr 10;18(4):1197-1209
pubmed: 28245646
Int J Mol Sci. 2013 Apr 26;14(5):9111-25
pubmed: 23624604
Nanomaterials (Basel). 2018 Jun 03;8(6):
pubmed: 29865277
Nanomaterials (Basel). 2017 Dec 04;7(12):
pubmed: 29207552
Adv Colloid Interface Sci. 2011 Aug 10;166(1-2):8-23
pubmed: 21601820
Nat Rev Drug Discov. 2003 Mar;2(3):214-21
pubmed: 12612647
Nanomaterials (Basel). 2020 Sep 25;10(10):
pubmed: 32993001
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Anticancer Drugs. 1999 Sep;10(8):767-76
pubmed: 10573209
Ann Surg Oncol. 2018 Jul;25(7):1783-1785
pubmed: 29671136
Adv Drug Deliv Rev. 2005 Dec 14;57(15):2177-202
pubmed: 16310284
Mol Neurobiol. 2016 Oct;53(8):5118-28
pubmed: 26395282
N Engl J Med. 1994 Feb 17;330(7):484-9
pubmed: 8289856
Int J Nanomedicine. 2016 Apr 27;11:1779-91
pubmed: 27175076
Theranostics. 2014 Jun 07;4(8):834-44
pubmed: 24955144
Materials (Basel). 2019 Feb 02;12(3):
pubmed: 30717431
Theranostics. 2013 Apr 23;3(6):366-76
pubmed: 23781284
ACS Nano. 2020 Jan 28;14(1):1033-1044
pubmed: 31935064
Drug Discov Today. 2005 Jan 1;10(1):35-43
pubmed: 15676297
J Clin Oncol. 2002 Sep 1;20(17):3628-36
pubmed: 12202663